By Denny Jacob
Dentsply Sirona initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business.
Wellspect, a provider of bladder and bowel management care products, has an estimated $2 billion total addressable market, said Dentsply.
"We look forward to determining an outcome for Wellspect that supports the business' enhanced growth trajectory and success while also enabling Dentsply Sirona to focus our resources and attention on our dental business," said Chief Executive Simon Campion.
The manufacturer and producer of dental products and technologies said there's no deadline or definitive timetable to complete the strategic alternatives process, or guarantee it will result in a transaction.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
February 11, 2025 09:04 ET (14:04 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.